What is the address of SARLA REMACLE – ANESTHESIOLOGIE?

The registered office of SARLA REMACLE – ANESTHESIOLOGIE is located at Rue Grande 24, 4260 Braives.

Is SARLA REMACLE – ANESTHESIOLOGIE still active?

Yes. According to the CBE (17 September 2026) SARLA REMACLE – ANESTHESIOLOGIE is active, legal situation “Normale toestand”, started on 25 January 2018.

Is SARLA REMACLE – ANESTHESIOLOGIE registered on Peppol?

Yes, SARLA REMACLE – ANESTHESIOLOGIE is registered on the Peppol network with ID 0208:0688895087.

What is the enterprise number of SARLA REMACLE – ANESTHESIOLOGIE?

The enterprise number of SARLA REMACLE – ANESTHESIOLOGIE is BE0688895087.

When was SARLA REMACLE – ANESTHESIOLOGIE founded?

SARLA REMACLE – ANESTHESIOLOGIE was founded on 25 January 2018.

Who are the directors of SARLA REMACLE – ANESTHESIOLOGIE?

According to the 2025 annual accounts, the directors of SARLA REMACLE – ANESTHESIOLOGIE are: SARLA CHARLOTTE REMACLE.

Is SARLA REMACLE – ANESTHESIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 January 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SARLA REMACLE – ANESTHESIOLOGIE make in 2025?

SARLA REMACLE – ANESTHESIOLOGIE posted a profit after taxes of € 79,344 in financial year 2025.

What is the revenue of SARLA REMACLE – ANESTHESIOLOGIE?

As a small company, SARLA REMACLE – ANESTHESIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 130,221.

SARLA REMACLE – ANESTHESIOLOGIE (Private Limited)

Dossier SARLA REMACLE – ANESTHESIOLOGIE, printed on 17 September 2026 from databakkes.be/en/0688895087/sarla-remacle-anesthesiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SARLA REMACLE – ANESTHESIOLOGIE from Braives, company number BE0688895087, closed financial year 2025 with a result of € 79,344 after tax. For that financial year SARLA REMACLE – ANESTHESIOLOGIE recorded a gross margin of € 130,221 and equity of € 1. Compared with financial year 2024, the result moved from € 40,170 to € 79,344. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Healthy

€ 1

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 79,344

▲ 98% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 145,655

▲ 122% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 79,344 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,696

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 79,376

▼ 15% vs 2024

€ 16,172 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 1,100

▲ € 944 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,540

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 16,191 Gross margin 2022: € 16,191 First fiscal year in the series	€ 77,123 Gross margin 2023: € 77,123 ▲ € 60,932 vs 2022 (€ 16,191) Favourable step	€ 79,790 Gross margin 2024: € 79,790 ▲ 3% vs 2023 (€ 77,123) Favourable step	€ 130,221 Gross margin 2025: € 130,221 ▲ 63% vs 2024 (€ 79,790) Favourable step	▲ 63%
Profit after taxes	€ -14,036 Profit after taxes 2022: € -14,036 First fiscal year in the series	€ 38,063 Profit after taxes 2023: € 38,063 ▲ € 52,098 vs 2022 (€ -14,036) Favourable step	€ 40,170 Profit after taxes 2024: € 40,170 ▲ 6% vs 2023 (€ 38,063) Favourable step	€ 79,344 Profit after taxes 2025: € 79,344 ▲ 98% vs 2024 (€ 40,170) Favourable step	▲ 98%
Equity	€ 20,460 Equity 2022: € 20,460 First fiscal year in the series	€ 20,460 Equity 2023: € 20,460 Unchanged (€ 20,460) Unchanged	€ 1 Equity 2024: € 1 ▼ € 20,459 vs 2023 (€ 20,460) Unfavourable step	€ 1 Equity 2025: € 1 Unchanged (€ 1) Unchanged
Total debts	€ 206,634 Total debts 2022: € 206,634 First fiscal year in the series	€ 172,379 Total debts 2023: € 172,379 ▼ 17% vs 2022 (€ 206,634) Favourable step	€ 149,616 Total debts 2024: € 149,616 ▼ 13% vs 2023 (€ 172,379) Favourable step	€ 213,790 Total debts 2025: € 213,790 ▲ 43% vs 2024 (€ 149,616) Unfavourable step	▲ 43%
Cash	€ 62,944 Cash 2022: € 62,944 First fiscal year in the series	€ 60,578 Cash 2023: € 60,578 ▼ 4% vs 2022 (€ 62,944) Unfavourable step	€ 65,727 Cash 2024: € 65,727 ▲ 8% vs 2023 (€ 60,578) Favourable step	€ 145,655 Cash 2025: € 145,655 ▲ 122% vs 2024 (€ 65,727) Favourable step	▲ 122%
Retained profit	€ 1,860 Retained profit 2022: € 1,860 First fiscal year in the series	€ 1,860 Retained profit 2023: € 1,860 Unchanged (€ 1,860) Unchanged	€ 0 Retained profit 2024: € 0 ▼ 100% vs 2023 (€ 1,860) Unfavourable step	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 41,695 Dividend 2022: € 41,695 First fiscal year in the series	€ 38,063 Dividend 2023: € 38,063 ▼ 9% vs 2022 (€ 41,695) Unchanged	€ 42,030 Dividend 2024: € 42,030 ▲ 10% vs 2023 (€ 38,063) Unchanged	€ 79,344 Dividend 2025: € 79,344 ▲ 89% vs 2024 (€ 42,030) Unchanged	▲ 89%
Bank debt	€ 124,616 Bank debt 2022: € 124,616 First fiscal year in the series	€ 109,099 Bank debt 2023: € 109,099 ▼ 12% vs 2022 (€ 124,616) Favourable step	€ 93,367 Bank debt 2024: € 93,367 ▼ 14% vs 2023 (€ 109,099) Favourable step	€ 79,376 Bank debt 2025: € 79,376 ▼ 15% vs 2024 (€ 93,367) Favourable step	▼ 15%
Balance sheet total	€ 227,094 Balance sheet total 2022: € 227,094 First fiscal year in the series	€ 192,839 Balance sheet total 2023: € 192,839 ▼ 15% vs 2022 (€ 227,094) Unchanged	€ 149,617 Balance sheet total 2024: € 149,617 ▼ 22% vs 2023 (€ 192,839) Unchanged	€ 213,791 Balance sheet total 2025: € 213,791 ▲ 43% vs 2024 (€ 149,617) Unchanged	▲ 43%

Key figures of SARLA REMACLE – ANESTHESIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SARLA REMACLE – ANESTHESIOLOGIE?

What happened at SARLA REMACLE – ANESTHESIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 79,344 (▲ 98% vs 2024). Source: NBB ↗
Apr 13, 2018 New establishment in Verviers. KBO
Jan 25, 2018 Start of the company according to the CBE. KBO

In short

From € 14,036 loss in 2022 to € 79,344 profit in 2025.

Paid € 43,702 in corporate taxes since 2022.

Best year ever: 2025, with € 79,344 profit.

Paid out € 201,132 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at SARLA REMACLE – ANESTHESIOLOGIE? We notify you, reason included.

Follow SARLA REMACLE – ANESTHESIOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

SARLA CHARLOTTE REMACLE

SARLA REMACLE – ANESTHESIOLOGIE

Behind SARLA REMACLE – ANESTHESIOLOGIE is SARLA CHARLOTTE REMACLE.

See the full network in the app

Directors

According to the 2025 annual accounts

SARLA CHARLOTTE REMACLE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Grande 24

4260 Braives

2.274.783.523

Rue du Naimeux 17

4802 Verviers

Active since 13 April 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0688.895.087
VAT number: BE 0688.895.087
Registered office: Rue Grande 24, 4260 Braives
Names & denominations: SARLA REMACLE – ANESTHESIOLOGIE · SRAnesth
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 January 2018
Peppol: Active · Active since 2 Dec 2024

View on CBE Public ↗ Annual accounts (NBB) ↗